GW&K Investment Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2K | Sell |
|
|||||
|
2021
Q3 | $25M | Sell |
|
|||||
|
2021
Q2 | $31.8M | Buy |
|
|||||
|
2021
Q1 | $46.5M | Sell |
|
|||||
|
2020
Q4 | $56.4M | Buy |
|
|||||
|
2020
Q3 | $47.8M | Buy |
|
|||||
|
2020
Q2 | $28.6M | Buy |
|
|||||
|
2020
Q1 | $217K | Sell |
|
|||||
|
2019
Q4 | $341K | Sell |
|
|||||
|
2019
Q3 | $350K | Buy |
|
|||||
|
2019
Q2 | $323K | Sell |
|
|||||
|
2019
Q1 | $339K | Buy |
|
|||||
|
2018
Q4 | $397K | Buy |
|
|||||
|
2018
Q3 | $438K | Buy |
|
|||||
|
2018
Q2 | $329K | Buy |
|
|||||
|
2018
Q1 | $319K | Buy |
|
|||||
|
2017
Q4 | $200K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3.16M | Buy |
|
|||||
|
2016
Q1 | $3.64M | Buy |
|
|||||
|
2015
Q4 | $2.16M | Sell |
|
|||||
|
2015
Q3 | $1.55M | Buy |
|
|||||
|
2015
Q2 | $1.76M | Sell |
|
|||||
|
2015
Q1 | $1.58M | Buy |
|
|||||
|
2014
Q4 | $1.11M | Buy |
|
|||||
|
2014
Q3 | $748K | Buy |
|
|||||
|
2014
Q2 | $609K | Buy |
|
|||||
|
2014
Q1 | $413K | Buy |
|
|||||
|
2013
Q4 | $330K | Buy |
|
|||||
|
2013
Q3 | $230K | Buy |
|
|||||
|
2013
Q2 | $155K | Buy |
|